Overview of Dr. Rubin
Dr. Mishaela Rubin is an endocrinologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. She received her medical degree from Columbia University Vagelos College of Physicians and Surgeons and has been in practice 22 years. Dr. Rubin accepts several types of health insurance, listed below. She is one of 142 doctors at New York-Presbyterian Hospital and one of 58 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Endocrinology. She has more than 100 publications and over 500 citings.
Office
180 Fort Washington Ave
New York, NY 10032Fax+1 212-342-0501
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Endocrinology, Diabetes, and Metabolism, 1999 - 2002
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1995 - 1998
- Columbia University Vagelos College of Physicians and SurgeonsClass of 1995
Certifications & Licensure
- NY State Medical License 1996 - 2026
- NJ State Medical License 1998 - 2025
Clinical Trials
- Primary Hyperparathyroidism (PHPT): Early Effect of Vitamin D Start of enrollment: 2010 May 01
- Therapy of the Skeletal Disease of Type 2 Diabetes With Denosumab Start of enrollment: 2018 Nov 07
- Advanced Glycation Endproducts and Bone Material Strength in T2D Treated With Pyridoxamine Start of enrollment: 2018 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- 141 citationsCirculating osteogenic precursor cells in type 2 diabetes mellitus.John S. Manavalan, Serge Cremers, David W. Dempster, Hua Zhou, Elzbieta Dworakowski
The Journal of Clinical Endocrinology and Metabolism. 2012-06-27 - 36 citationsParathyroid hormone stimulates circulating osteogenic cells in hypoparathyroidism.Mishaela R. Rubin, John S. Manavalan, David W. Dempster, Jayesh Shah, Serge Cremers
The Journal of Clinical Endocrinology and Metabolism. 2011-04-30 - 16 citationsEffects of Rosiglitazone vs Metformin on Circulating Osteoclast and Osteogenic Precursor Cells in Postmenopausal Women with Type 2 Diabetes MellitusMishaela R. Rubin, John S. Manavalan, Sanchita Agarwal, Donald J. McMahon, Antonio Nino
The Journal of Clinical Endocrinology and Metabolism. 2014-06-06
Journal Articles
- Comparative Effect of rhPTH(1‐84) on Bone Mineral Density and Trabecular Bone Score in Hypoparathyroidism and Postmenopausal OsteoporosisMishaela R Rubin, Donald J McMahon, John P Bilezikian, Natalie E Cusano, Journal of Bone and Mineral Research
Press Mentions
- The Hypoparathyroidism Association Announces Patient Enrollment in First Prospective Hypoparathyroidism Natural History StudyMay 23rd, 2023
- TransCon PTH Nears U.S. Approval for Hypoparathyroidism?May 17th, 2023
- Ascendis Pharma A/S Presents 6-Month Open-Label Extension Data from Phase 2 PaTH Forward Trial of TransCon PTH in Adult Hypoparathyroidism at ENDO 2021March 23rd, 2021
- Join now to see all
Grant Support
- The Skeletal Effects Of Reducing Inflammation In Type 2 Diabetes MellitusNational Institute Of Diabetes And Digestive And Kidney Diseases2010
- Circulating Osteoblast Lineage Cells In HypoparathyroidismNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2008
- Bone Quality In Hypoparathyroidism: Effects Of PTHNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2008
Insurance Accepted
- BCBS Blue Card PPO
BCBS Texas BlueChoice
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
Great West PPOMultiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: